Sage Journals: Discover world-class research

Free access

Review article

First published 2013-4

The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update

Raymond Lai, Robert J. Ingham

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2003-10

Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL)

U. Ritter, C. Damm-Welk, U. Fuchs [...]

Nucleic Acid Therapeutics

Retricted access

Research article

First published 2001-3

Morphological and Phenotypic Features in Pediatric Large Cell Lymphoma and Their Correlation with ALK Expression and the t(2;5)(p23;q35) Translocation

C.G. Sherman, M. Zielenska, A.N. Lorenzana [...]

Pediatric and Developmental Pathology

Retricted access

Research article

First published 2012-07

EML4-ALK-Positive Non-Small Cell Lung Cancer in a Patient Treated with Azathioprine for Ulcerative Colitis

Irena Lazarev, Netta Sion-Vardy, Samuel Ariad

Tumori Journal

Free access

Research article

First published 2011-2

Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor

Allison E. Drew, Samer Al-Assaad, Violeta Yu [...]

Journal of Biomolecular Screening

Retricted access

Case report

First published 2019-7

A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma

Barbara M Parker, John V Parker, Anastasios Lymperopoulos [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2015

Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells

Amit Dipak Amin, Soumya S. Rajan, Matthew J. Groysman [...]

Biomarkers in Cancer

Search results

The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update

Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL)

Morphological and Phenotypic Features in Pediatric Large Cell Lymphoma and Their Correlation with ALK Expression and the t(2;5)(p23;q35) Translocation

EML4-ALK-Positive Non-Small Cell Lung Cancer in a Patient Treated with Azathioprine for Ulcerative Colitis

Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor

A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma

Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells